Royal Bank of Canada’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.6M Buy
453,402
+61,986
+16% +$5.14M 0.01% 1002
2025
Q1
$31.7M Sell
391,416
-101,176
-21% -$8.21M 0.01% 928
2024
Q4
$44.4M Sell
492,592
-453,293
-48% -$40.8M 0.01% 805
2024
Q3
$93.5M Sell
945,885
-73,434
-7% -$7.26M 0.02% 526
2024
Q2
$94.5M Sell
1,019,319
-59,142
-5% -$5.48M 0.02% 496
2024
Q1
$102M Buy
1,078,461
+349,519
+48% +$33.2M 0.02% 476
2023
Q4
$65.1M Sell
728,942
-32,825
-4% -$2.93M 0.02% 605
2023
Q3
$55.6M Buy
761,767
+176,631
+30% +$12.9M 0.02% 587
2023
Q2
$48.7M Sell
585,136
-23,549
-4% -$1.96M 0.01% 644
2023
Q1
$46.4M Sell
608,685
-34,171
-5% -$2.6M 0.01% 647
2022
Q4
$53.4M Sell
642,856
-11,892
-2% -$987K 0.02% 596
2022
Q3
$51.9M Buy
654,748
+134,852
+26% +$10.7M 0.02% 563
2022
Q2
$38.6M Sell
519,896
-97,501
-16% -$7.24M 0.01% 700
2022
Q1
$55.5M Buy
617,397
+65,463
+12% +$5.88M 0.01% 620
2021
Q4
$61.8M Buy
551,934
+135,797
+33% +$15.2M 0.01% 630
2021
Q3
$52.3M Buy
416,137
+47,516
+13% +$5.97M 0.01% 646
2021
Q2
$49.9M Buy
368,621
+8,870
+2% +$1.2M 0.01% 689
2021
Q1
$48.8M Sell
359,751
-46,579
-11% -$6.32M 0.01% 650
2020
Q4
$57.2M Sell
406,330
-335,362
-45% -$47.2M 0.02% 558
2020
Q3
$82.6M Sell
741,692
-34,834
-4% -$3.88M 0.03% 383
2020
Q2
$86.9M Sell
776,526
-57,029
-7% -$6.38M 0.03% 353
2020
Q1
$64.6M Buy
833,555
+354,685
+74% +$27.5M 0.03% 374
2019
Q4
$45.5M Sell
478,870
-375,340
-44% -$35.7M 0.02% 574
2019
Q3
$65.1M Buy
854,210
+107,891
+14% +$8.23M 0.03% 425
2019
Q2
$65.5M Buy
746,319
+250,476
+51% +$22M 0.03% 418
2019
Q1
$44.9M Sell
495,843
-134,332
-21% -$12.2M 0.02% 520
2018
Q4
$45.2M Buy
630,175
+6,465
+1% +$464K 0.02% 461
2018
Q3
$59.8M Buy
623,710
+65,143
+12% +$6.25M 0.02% 432
2018
Q2
$53.2M Sell
558,567
-9,413
-2% -$896K 0.02% 462
2018
Q1
$49.8M Buy
567,980
+134,293
+31% +$11.8M 0.02% 504
2017
Q4
$36.8M Sell
433,687
-37,306
-8% -$3.17M 0.02% 633
2017
Q3
$40.8M Sell
470,993
-7,187
-2% -$622K 0.02% 562
2017
Q2
$36.9M Buy
478,180
+130,273
+37% +$10.1M 0.02% 587
2017
Q1
$24.1M Sell
347,907
-78,043
-18% -$5.41M 0.01% 772
2016
Q4
$25.2M Sell
425,950
-35,164
-8% -$2.08M 0.01% 748
2016
Q3
$30.6M Sell
461,114
-10,885
-2% -$722K 0.02% 621
2016
Q2
$25.5M Buy
471,999
+177,607
+60% +$9.61M 0.02% 678
2016
Q1
$15.2M Sell
294,392
-34,984
-11% -$1.81M 0.01% 955
2015
Q4
$23.1M Buy
329,376
+213,536
+184% +$15M 0.02% 744
2015
Q3
$7.21M Sell
115,840
-274,610
-70% -$17.1M 0.01% 1113
2015
Q2
$32.8M Buy
390,450
+10,107
+3% +$850K 0.02% 516
2015
Q1
$28.6M Buy
380,343
+322,794
+561% +$24.3M 0.02% 561
2014
Q4
$3.58M Sell
57,549
-11,181
-16% -$695K ﹤0.01% 1541
2014
Q3
$3.57M Buy
68,730
+12,057
+21% +$627K ﹤0.01% 1549
2014
Q2
$2.91M Sell
56,673
-14,880
-21% -$764K ﹤0.01% 1708
2014
Q1
$3.4M Buy
71,553
+13,230
+23% +$628K ﹤0.01% 1565
2013
Q4
$2.53M Sell
58,323
-59,235
-50% -$2.57M ﹤0.01% 1706
2013
Q3
$5.06M Sell
117,558
-45,939
-28% -$1.98M ﹤0.01% 1281
2013
Q2
$5.68M Buy
+163,497
New +$5.68M ﹤0.01% 1109